EPIGENESIS PHARMACEUTICALS
DEAD

Serial Number

78355970

Owner

Epigenesis Pharmaceuticals, LLC

Attorney

ALBERT P. HALLUIN

Filing Date

Jan 22, 2004

Add to watchlist:

No watchlists yet
View on USPTO

EPIGENESIS PHARMACEUTICALS Trademark

Serial Number: 78355970

EPIGENESIS PHARMACEUTICALS is a trademark filed by Epigenesis Pharmaceuticals, LLC on January 22, 2004. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Epigenesis Pharmaceuticals, LLC (13 trademarks)

2009 Eastpark Boulevard
Cranbury, NJ 08512

Entity Type: 16

EPIGENESIS Pharmaceuticals, Inc. (26 trademarks)

2055 East Park
Cranbury, NJ 08512

Entity Type: 03

Trademark Details

Filing Date

January 22, 2004

Registration Date

Not Registered

Published for Opposition

July 5, 2005

Goods & Services

Medical diagnostic and therapeutic preparations, all for administration via diverse routes of administration including through the respiratory airways, and, medical devices for administering the pharmaceuticals, sold filled, the preparations including nucleotides, proteins and organic molecules for medical use, including macromolecules such as anti-sense oligonucleotides and enzymes and small and inorganic molecules for treatment of human and non-human animal respiratory, central nervous system, neoplastic, endocrine, immune and cardiovascular ailments, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in some cases are adenosine receptor associated symptoms; pharmaceutical preparations for testing, and preventing and therapeutically treating respiratory, airway and pulmonary diseases and conditions, such as asthma, pulmonary vasconconstriction, inflammation, allergies, impeded respiration, acute respiratory disease syndrome (ARDS), renal damage and failure, ischemia resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating supra ventricular tachycardia (SVT), adenosine stress tests, infantile respiratory distress syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vasconcontriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, eg colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, etc, as well as metastatic cancers, eg, cancers which metastasized to the lung(s), breast, liver and prostate

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Oct 27, 2008 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 27, 2008 ABN6
SOU EXTENSION 5 GRANTED
Apr 4, 2008 EX5G
SOU EXTENSION 5 FILED
Mar 14, 2008 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 14, 2008 EEXT
SOU EXTENSION 4 GRANTED
Sep 26, 2007 EX4G
SOU EXTENSION 4 FILED
Sep 13, 2007 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 13, 2007 EEXT
SOU EXTENSION 3 GRANTED
Jun 28, 2007 EX3G
SOU EXTENSION 3 FILED
Mar 20, 2007 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 20, 2007 EEXT
SOU EXTENSION 2 GRANTED
Oct 24, 2006 EX2G
SOU EXTENSION 2 FILED
Sep 22, 2006 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 22, 2006 EEXT
SOU EXTENSION 1 GRANTED
Apr 28, 2006 EX1G
SOU EXTENSION 1 FILED
Mar 24, 2006 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 24, 2006 EEXT
NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 27, 2005 NOAM
PUBLISHED FOR OPPOSITION
Jul 5, 2005 PUBO
NOTICE OF PUBLICATION
Jun 15, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 28, 2005 PREV
ASSIGNED TO LIE
Mar 25, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 18, 2005 CNSA
AMENDMENT FROM APPLICANT ENTERED
Mar 17, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2005 CRFA
PAPER RECEIVED
Jan 31, 2005 MAIL
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 5, 2004 TCCA
NON-FINAL ACTION E-MAILED
Aug 21, 2004 GNRT
ASSIGNED TO EXAMINER
Aug 12, 2004 DOCK
TEAS VOLUNTARY AMENDMENT RECEIVED
Jul 20, 2004 PARI
PAPER RECEIVED
Jul 16, 2004 MAIL
NEW APPLICATION ENTERED
Feb 2, 2004 NWAP